Afficher la notice abrégée

dc.rights.licenseopenen_US
hal.structure.identifierInstitut de Neurosciences cognitives et intégratives d'Aquitaine [INCIA]
dc.contributor.authorTESSIER, Arnaud
dc.contributor.authorROGER, Karine
dc.contributor.authorGREGOIRE, Alexandra
dc.contributor.authorDESNAVAILLES, Pauline
hal.structure.identifierInstitut de Neurosciences cognitives et intégratives d'Aquitaine [INCIA]
dc.contributor.authorMISDRAHI, David
dc.date.accessioned2023-11-02T13:31:21Z
dc.date.available2023-11-02T13:31:21Z
dc.date.issued2023-01-01
dc.identifier.issn1664-0640en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/184578
dc.description.abstractEnSchizophrenia is recognized for its severe impact on both patients and caregivers. In a 12-month follow-up randomized clinical trial, we aimed to measure the efficacy of a brief family psychoeducation program in terms of reducing relapse risk and improving medication adherence in patients, as well as reducing caregiver burden, depression and increasing knowledge of the illness. A total of 25 days of patients with schizophrenia (DSM-IV-TR) and family primary caregivers were recruited in a single regional psychiatric outpatient facility located in Bordeaux. In the active group, caregivers received a psychoeducational intervention consisting of six sessions spread over 1.5 months, while the control group was placed on a waiting list. Sociodemographic, symptom severity (PANSS) and medication adherence (MARS) from patients were assessed at baseline and relapse rates was recorded during the 12 months follow-up period. Caregivers' burden (ZBI), depression (CES-D), quality of life (S-CGQoL), knowledge of the disease (KAST) and therapeutic alliance (4PAS-C) were assessed at baseline, three and 6 months. On the 25 patients included, the mean age was 33.3 years (SD = 9.7) with a mean duration of disease of 7.48 years (SD = 7.1). On the 25 caregivers included, the mean age was 50.6 years (SD = 14.0). Twenty-one were female (84.0%), 12 were married (48.0%) and 11 lived alone (44.0%). For patients, the family psychoeducation intervention significantly reduced the risk of relapse with a significant effect found at 12 months follow-up ( = 0.014). No change was observed on medication adherence. For caregivers, the intervention reduced the burden ( = 0.031), decreased the depression ( = 0.019), and increased the knowledge on schizophrenia ( = 0.024). Analyzes for repeated measures showed a statistically significant difference in therapeutic alliance ( = 0.035). As confirmed by previous studies, the brief multifamily program (consisting of six sessions over a period of 1.5 months) was found to be effective in improving outcomes for caregivers (e.g., burden, depression, knowledge) and patients (e.g., preventing relapse) in the context of routine care. Given its short duration, this program is expected to be easily implementable within the community. https://clinicaltrials.gov/, NCT03000985.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.title.enFamily psychoeducation to improve outcome in caregivers and patients with schizophrenia: a randomized clinical trial
dc.title.alternativeFront Psychiatryen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.3389/fpsyt.2023.1171661en_US
dc.subject.halSciences du Vivant [q-bio]/Neurosciences [q-bio.NC]en_US
dc.identifier.pubmed37426102en_US
bordeaux.journalFrontiers in Psychiatryen_US
bordeaux.page1171661en_US
bordeaux.volume14en_US
bordeaux.hal.laboratoriesInstitut de neurosciences cognitives et intégratives d'Aquitaine (INCIA) - UMR 5287en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionCNRSen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.import.sourcepubmed
hal.identifierhal-04268202
hal.version1
hal.date.transferred2023-11-02T13:31:23Z
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
workflow.import.sourcepubmed
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Frontiers%20in%20Psychiatry&rft.date=2023-01-01&rft.volume=14&rft.spage=1171661&rft.epage=1171661&rft.eissn=1664-0640&rft.issn=1664-0640&rft.au=TESSIER,%20Arnaud&ROGER,%20Karine&GREGOIRE,%20Alexandra&DESNAVAILLES,%20Pauline&MISDRAHI,%20David&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée